Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-05 Purchase | 2024-12-09 4:52 pm | Aurinia Pharmaceuticals Inc. | AUPH | TANG KEVIN Director | 1,200,000 | $9.0183 | $10,822,000 | 8,429,500 (Indirect) | View |
| 2024-11-11 Sale | 2024-11-12 7:29 pm | Aurinia Pharmaceuticals Inc. | AUPH | Bailey Jeffrey Allen Director | 4,557 | $8.43 | $38,416 | 13,356 (Direct) | View |
| 2024-11-11 Sale | 2024-11-12 7:20 pm | Aurinia Pharmaceuticals Inc. | AUPH | Smith Karen L. Director | 5,241 | $8.43 | $44,182 | 12,672 (Direct) | View |
| 2024-08-06 Sale | 2024-08-08 4:06 pm | Aurinia Pharmaceuticals Inc. | AUPH | Habig Scott Michael Chief Commercial Officer | 18,249 | $5.31 | $96,902 | 456,338 (Direct) | View |
| 2024-05-21 Sale | 2024-05-22 4:16 pm | Aurinia Pharmaceuticals Inc. | AUPH | Balakrishnan Brinda Director | 520 | $5.74 | $2,985 | 17,523 (Direct) | View |
| 2024-05-21 Sale | 2024-05-22 4:14 pm | Aurinia Pharmaceuticals Inc. | AUPH | Billen Daniel Director | 5,252 | $5.74 | $30,146 | 28,141 (Direct) | View |
| 2024-05-21 Sale | 2024-05-22 4:11 pm | Aurinia Pharmaceuticals Inc. | AUPH | Jayne David R.W. Director | 4,946 | $5.74 | $28,390 | 44,364 (Direct) | View |
| 2024-05-21 Sale | 2024-05-22 4:09 pm | Aurinia Pharmaceuticals Inc. | AUPH | Leversage Jill Director | 5,610 | $5.74 | $32,201 | 12,918 (Direct) | View |
| 2024-05-21 Sale | 2024-05-22 4:07 pm | Aurinia Pharmaceuticals Inc. | AUPH | MacKay-Dunn R. Hector Director | 5,630 | $5.74 | $32,316 | 18,595 (Direct) | View |
| 2024-03-06 Sale | 2024-03-07 4:46 pm | Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer | 126,981 | $5.6 | $711,094 | 1,522,114 (Direct) | View |
| 2024-03-06 Sale | 2024-03-07 4:44 pm | Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer | 34,811 | $5.6 | $194,942 | 495,928 (Direct) | View |
| 2024-03-06 Sale | 2024-03-07 4:43 pm | Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell EVP, Ops & Strategy | 40,665 | $5.51 | $224,064 | 584,072 (Direct) | View |
| 2024-03-06 Sale | 2024-03-07 4:42 pm | Aurinia Pharmaceuticals Inc. | AUPH | Habig Scott Michael Chief Commercial Officer | 17,777 | $5.6 | $99,551 | 474,587 (Direct) | View |
| 2024-03-06 Sale | 2024-03-07 4:41 pm | Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel | 57,745 | $5.6 | $323,372 | 443,824 (Direct) | View |
| 2024-02-27 Sale | 2024-02-29 4:11 pm | Aurinia Pharmaceuticals Inc. | AUPH | Knappertz Volker EVP, Research and Development | 4,930 | $6.1 | $30,073 | 319,128 (Direct) | View |
| 2024-02-20 Sale | 2024-02-22 4:35 pm | Aurinia Pharmaceuticals Inc. | AUPH | Knappertz Volker EVP, Research and Development | 25,146 | $5.48 | $137,800 | 324,058 (Direct) | View |
| 2024-02-20 Sale | 2024-02-22 4:33 pm | Aurinia Pharmaceuticals Inc. | AUPH | Habig Scott Michael Chief Commercial Officer | 15,867 | $5.48 | $86,951 | 492,364 (Direct) | View |
| 2023-03-02 Sale(A) | 2024-02-22 4:19 pm | Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel | 19,644 | $8.78 | $172,474 | 303,122 (Direct) | View |
| 2023-03-02 Sale(A) | 2024-02-22 4:17 pm | Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer | 11,398 | $8.78 | $100,074 | 331,112 (Direct) | View |
| 2023-03-02 Sale(A) | 2024-02-22 4:15 pm | Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer | 33,047 | $8.78 | $290,153 | 982,671 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-21 Option Award | 2024-11-25 4:38 pm | N/A 2034-11-21 | Aurinia Pharmaceuticals Inc. | AUPH | Smith Karen L. Director | 30,776 | $0 | 43,448 (Direct) | View |
| 2024-11-21 Option Award | 2024-11-25 4:36 pm | N/A 2034-11-21 | Aurinia Pharmaceuticals Inc. | AUPH | Leversage Jill Director | 30,776 | $0 | 43,694 (Direct) | View |
| 2024-11-21 Option Award | 2024-11-25 4:33 pm | N/A 2034-11-21 | Aurinia Pharmaceuticals Inc. | AUPH | Johnson Craig A Director | 52,319 | $0 | 52,319 (Direct) | View |
| 2024-11-21 Option Award | 2024-11-25 4:30 pm | N/A 2034-11-21 | Aurinia Pharmaceuticals Inc. | AUPH | Bailey Jeffrey Allen Director | 30,776 | $0 | 44,132 (Direct) | View |
| 2024-11-21 Option Award | 2024-11-25 4:28 pm | N/A 2034-11-21 | Aurinia Pharmaceuticals Inc. | AUPH | Jayne David R.W. Director | 30,776 | $0 | 75,140 (Direct) | View |
| 2024-11-08 Exercise | 2024-11-12 7:29 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Bailey Jeffrey Allen Director | 17,913 | $0 | 13,356 (Direct) | View |
| 2024-11-08 Exercise | 2024-11-12 7:20 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Smith Karen L. Director | 17,913 | $0 | 12,672 (Direct) | View |
Ownership | 2024-11-12 7:05 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Keenan Greg Chief Medical Officer | 0 | $0 | 193,435 (Direct) | View |
Ownership | 2024-09-23 4:05 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | TANG KEVIN Director | 0 | $0 | 10,229,500 (Indirect) | View |
| 2024-02-20 Option Award | 2024-02-22 4:33 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Habig Scott Michael Chief Commercial Officer | 195,512 | $0 | 492,364 (Direct) | View |
| 2024-02-20 Option Award | 2024-02-22 4:31 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell EVP, Ops & Strategy | 216,666 | $0 | 624,737 (Direct) | View |
| 2024-02-20 Option Award | 2024-02-22 4:29 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel | 194,230 | $0 | 501,569 (Direct) | View |
| 2024-02-20 Option Award | 2024-02-22 4:27 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer | 196,153 | $0 | 530,739 (Direct) | View |
| 2024-02-20 Option Award | 2024-02-22 4:25 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer | 661,538 | $0 | 1,649,095 (Direct) | View |
| 2023-09-21 Option Award | 2023-09-22 4:36 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Foster Robert T Director | 53,283 | $0 | 53,283 (Direct) | View |
| 2023-08-18 Option Award | 2023-08-21 4:25 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Bailey Jeffrey Allen Director | 46,872 | $0 | 46,872 (Direct) | View |
| 2023-08-18 Option Award | 2023-08-21 4:19 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Smith Karen L. Director | 46,872 | $0 | 46,872 (Direct) | View |
| 2023-05-18 Exercise | 2023-05-23 5:22 pm | 2023-05-18 N/A | Aurinia Pharmaceuticals Inc. | AUPH | Balakrishnan Brinda Director | 8,733 | $0 | 33,277 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-23 5:22 pm | N/A 2033-05-19 | Aurinia Pharmaceuticals Inc. | AUPH | Balakrishnan Brinda Director | 24,544 | $0 | 33,277 (Direct) | View |